Allopurinol and markers of muscle damage among participants in the Tour de France

JAMA. 2003 May 21;289(19):2503-4. doi: 10.1001/jama.289.19.2503-b.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allopurinol / pharmacology*
  • Aspartate Aminotransferases / blood
  • Bicycling / physiology*
  • Biomarkers / blood
  • Creatine Kinase / blood
  • Enzyme Inhibitors / pharmacology*
  • Free Radical Scavengers / pharmacology*
  • Humans
  • Muscle, Skeletal / physiology*
  • Physical Exertion / physiology*
  • Xanthine Oxidase / antagonists & inhibitors*

Substances

  • Biomarkers
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Allopurinol
  • Xanthine Oxidase
  • Aspartate Aminotransferases
  • Creatine Kinase